TAIPEI, Feb. 17, 2025 /PRNewswire/ — Ergothioneine, known for their exceptional nutritional value, have been gaining significant global attention as a key ingredient in dietary supplements. According to market data, the global Ergothioneine supplement market is projected to reach USD 34.3 billion in 2024 and grow to USD 47.2 billion by 2028, highlighting vast consumer demand and market potential.
Empowering Brands from Production to Sustainability
Welbloom Bio-Tech, a leading Taiwanese contract development and manufacturing organization (CDMO) specializing in dietary supplements, is set to exhibit at the upcoming Natural Products Expo West (NPEW) in March. The company will unveil two innovative products—Wel-EGT® and Wel-Revive®—addressing the evolving health and wellness trends.
Founded in 1999, Welbloom Bio-Tech comprises a team of professionals with backgrounds in pharmaceuticals, food science, and nutrition. The company operates an NSF-certified manufacturing facility, offering tailored solutions across the entire product lifecycle, from formulation development and production to training and education.
Welbloom Bio-Tech takes pride in its proprietary FRESH-Jelly® technology, an industry-first patented delivery format. The company’s commitment to sustainability is further demonstrated through its newly established LEED Silver-certified facility, which emphasizes the use of local ingredients and eco-friendly packaging while achieving carbon reduction goals.
Welbloom Showcasing New Exosome Technology
The company’s flagship product, Wel-EGT®, leverages a proprietary mushroom Exosomes extraction technology enriched with amino acids, providing rapid nutrient absorption and boasting a remarkable 92% free radical scavenging rate per milliliter.
In response to the aging population trend, Welbloom Bio-Tech will also unveil Wel-Revive®, a powerful anti-aging supplement formulated with turmeric, onion, and strawberry extracts. This compound formula is designed to combat oxidative stress and cellular aging, delivering noticeable results within just four weeks of use.
NPEW will take place from March 5 to March 7 in Anaheim, California, where Welbloom Bio-Tech will exhibit at Hall D, Booth #3367. Industry professionals interested in exploring the latest innovations, especially the application of Exosomes in ingredients and formulations, are welcome to visit the booth or contact Jenny Zhu at service@welbloom.com.tw for further inquiries and collaboration opportunities.
Media Contact
Jenny Zhu
+886 2 33225555
390339@email4pr.com
SOURCE Welbloom Bio-Tech
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…